angiotensin ii has been researched along with Carcinoma, Lewis Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, L; Feng, Y; Guo, Y; Li, QY; Ni, L; Qian, YR; Wan, HY; Xiang, Y | 1 |
| Hattori, Y; Kawano, K; Maitani, Y; Ubukata, H | 1 |
2 other study(ies) available for angiotensin ii and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Hypoxia induces dysregulation of local renin-angiotensin system in mouse Lewis lung carcinoma cells.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Carcinoma, Lewis Lung; Cell Hypoxia; Gene Expression Regulation, Neoplastic; Humans; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 2; Renin-Angiotensin System | 2014 |
Angiotensin II-induced hypertension enhanced therapeutic efficacy of liposomal doxorubicin in tumor-bearing mice.
Topics: Angiotensin II; Animals; Antibiotics, Antineoplastic; Blood Circulation; Carcinoma, Lewis Lung; Colonic Neoplasms; Doxorubicin; Female; Hypertension; Injections, Intravenous; Liposomes; Mice; Mice, Inbred Strains; Tissue Distribution | 2011 |